NIH/National Institute of Allergy and Infectious Diseases
NIH-funded analysis estimates effective PrEP dosing
Several large clinical trials have demonstrated that a daily oral dose of one or two antiretroviral drugs used to treat HIV infection can prevent infection in an approach known as pre-exposure prophylaxis, or PrEP. The level ...
HIV & AIDS
Sep 13, 2012 |
not rated yet |
0
Reconstructed 1918 influenza virus has yielded key insights, scientists say
The genetic sequencing and reconstruction of the 1918 influenza virus that killed 50 million people worldwide have advanced scientists' understanding of influenza biology and yielded important information on how to prevent ...
Diseases, Conditions, Syndromes
Sep 11, 2012 |
not rated yet |
0
Knowing origin of broadly neutralizing antibodies could aid universal flu vaccine design
National Institutes of Health scientists have identified how a kind of immature immune cell responds to a part of influenza virus and have traced the path those cells take to generate antibodies that can neutralize a wide ...
Medical research
Aug 29, 2012 |
not rated yet |
0
|
Researchers find possible cause of immune deficiency cases in Asia
A clinical study led by National Institutes of Health investigators has identified an antibody that compromises the immune systems of HIV-negative people, making them susceptible to infections with opportunistic microbes ...
Immunology
Aug 22, 2012 |
3.7 / 5 (3) |
0
|
Study suggests potential hurdle to universal flu vaccine development may be overcome
In the quest for a universal influenza vaccine—one that elicits broadly neutralizing antibodies that can protect against most or all strains of flu virus—scientists have faced a sobering question: Does pre-existing ...
Diseases, Conditions, Syndromes
Aug 15, 2012 |
not rated yet |
0
|
Landmark HIV treatment-as-prevention study shows additional health benefits, cost-effectiveness
WHAT: Further analyses of the landmark NIH-funded treatment-as-prevention study (HPTN 052) have found that providing antiretroviral treatment to HIV-infected individuals earlier, when their immune systems are healthier, delays ...
HIV & AIDS
Jul 27, 2012 |
not rated yet |
0
NIH team describes protective role of skin microbiota
A research team at the National Institutes of Health has found that bacteria that normally live in the skin may help protect the body from infection. As the largest organ of the body, the skin represents a major site of interaction ...
Medical research
Jul 26, 2012 |
5 / 5 (3) |
0
|
NIH-funded study finds high HIV infection rates among gay and bisexual black men in the US
The rate of new HIV infections among black men who have sex with men (MSM) in the United States, particularly younger men, is high and suggests the need for prevention programs specifically tailored to this population, according ...
HIV & AIDS
Jul 26, 2012 |
not rated yet |
0
New HIV-inhibiting protein identified
Scientists have identified a new HIV-suppressing protein in the blood of people infected with the virus. In laboratory studies, the protein, called CXCL4 or PF-4, binds to HIV such that it cannot attach to or enter a human ...
HIV & AIDS
May 29, 2012 |
5 / 5 (3) |
0
|
Scientists link quickly spreading gene to Asian MRSA epidemic
National Institutes of Health (NIH) scientists and their colleagues in China have described a rapidly emerging Staphylococcus aureus gene, called sasX, which plays a pivotal role in establishing methicillin-resistant S. aureus (MRSA) ...
Genetics
Apr 22, 2012 |
5 / 5 (1) |
0
|
Screening effort turns up multiple potential anti-malaria compounds
Numerous potential anti-malarial candidate drugs have been uncovered by investigators from the National Institute of Allergy and Infectious Diseases (NIAID) and the National Human Genome Research Institute (NHGRI), both parts ...
Diseases, Conditions, Syndromes
Aug 04, 2011 |
not rated yet |
0
|
Scientists reactivate immune cells exhausted by chronic HIV
Scientists at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, have demonstrated why certain immune cells chronically exposed to HIV shut down, and how they can ...
HIV & AIDS
Jun 03, 2011 |
5 / 5 (1) |
0
|
- Pages: 1 2
